Therapy-related MDS/AML after autologous stem cell transplantation for lymphoma with BEAM as conditioning: our experience

Abstract

In our single center retrospective analysis we detected low incidence of tMDS/AML after ASCT with BEAM as the conditioning regimen. The crude incidence was 2,5% and 5-year cumulative incidence was 3%.

Keywords

• myelodysplastic syndrome
• secondary leukemia
• autologous stem cell transplantation